The FDA notices reads, in part:
‘The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., Piscataway, N.J. Sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle from Camber were found to instead contain 90 tablets of Losartan Potassium Tablets, 50 mg.
Montelukast is used to prevent wheezing, difficulty breathing, chest tightness and coughing caused by asthma. It is also used to prevent bronchospasm (breathing difficulties) during exercise and to treat the symptoms of seasonal and perennial allergic rhinitis. Montelukast is in a class of medications called leukotriene receptor antagonists (LTRAs) which work by blocking the action of substances in the body that cause the symptoms of asthma and allergic rhinitis
Montelukast sodium tablets are beige, rounded square-shaped, film coated tablets that are imprinted with “I” on one side and “114” on the reverse. Losartan tablets are white and oval-shaped with the letter “I” imprinted on one side and the number “5” imprinted on the reverse.
Recalled lots of montelukast sodium tablets, USP 10mg have the following information:
- Label: Montelucast Sodium Tablets 10 mg 30 ct
- Lot number: MON17384
- Expiration date: 12/31/2019
- NDC: 31722-726-30’
To read the full press release go to:
If you or a family member is taking Montelucast, Allergy Partners encourages you to check your prescription bottle to be sure it is not from this lot. If indeed it is, do not take the medication and contact your dispensing pharmacy. If you have any questions regarding your medication, please contact your dispensing pharmacy as well.